XBiotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$24,557,000 over the previous period. Total operating expenses were $37,510,000.

Profit Margin

XBiotech Inc. (NASDAQ:XBIT): Profit margin
2014 0 -21.72M
2015 0 -37.48M
2016 0 -52.76M
2017 0 -33.15M
2018 0 -21.13M
2019 0 668.62M
2020 43.99M -11.22M -25.5%
2021 18.39M -17.41M -94.67%
2022 4.01M -32.9M -820.45%
2023 0 -24.55M

XBIT Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
04.01M18.39M43.99M000000
Cost of revenue
1.74M651K5.82M34.54M2.36M01.48M0699K0
Gross profit
-1.74M3.35M12.57M9.44M-2.36M0-1.48M0-699K0
Operating exp.
Research and development
32.84M31.54M28.26M9.52M24.09M15.72M26.42M42.48M31.31M14.32M
Selling and marketing
0000000000
Total operating expenses
37.51M37.84M37.65M27.72M31.23M20.99M34.05M52.76M37.51M21.77M
Operating income
-37.51M-34.49M-25.08M-18.27M-31.23M-20.99M-34.05M-52.76M-37.51M-21.77M
Other income (expenses), net
13.19M902K-376K5.44M749.68M-544K909K-47K27K54K
Income before tax
-24.31M-33.58M-25.45M-12.82M718.45M-21.13M-33.15M-52.76M-37.48M-21.72M
Income tax expense
244K-688K-8.04M-1.60M49.82M-144K-909K-2K-6K-54K
Net income
-24.55M-32.9M-17.41M-11.22M668.62M-21.13M-33.15M-52.76M-37.48M-21.72M
Earnings per share
Basic EPS
-0.81-1.08-0.58-0.3617.17-0.59-0.95-1.63-1.22-0.68
Diluted EPS
-0.81-1.08-0.58-0.3614.44-0.59-0.95-1.63-1.22-0.68
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source